← Eichor
Condition: Cholesterol Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cholesterol

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

DESIFOR-EXPAND (MHIF)
Phase 4 · 1 location(s) · Minneapolis Heart Institute Foundation · NCT06804980Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Phase 4 · 4 location(s) · NYU Langone Health · NCT05641753Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
NA · 1 location(s) · University of Leipzig · NCT06526013Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers
NA · 2 location(s) · Fundació Eurecat · NCT06422741Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity
NA · 1 location(s) · Nantes University Hospital · NCT07027033Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NA · 1 location(s) · Washington University School of Medicine · NCT06894004Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-7
Phase 4 · 1 location(s) · Yonsei University · NCT03770312A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NA · 2 location(s) · University of Tennessee · NCT06374277Registry of Patients Diagnosed With Lysosomal Storage Diseases
Phase N/A · 1 location(s) · University of California, San Francisco · NCT05619900Lysosomal Acid Lipase (LAL) Deficiency Registry
Phase N/A · 104 location(s) · Alexion Pharmaceuticals, Inc. · NCT01633489Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
Phase 4 · 6 location(s) · Myungmoon Pharma. Co. Ltd. · NCT07005752Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NA · 22 location(s) · Stephen Nicholls · NCT05325034Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
NA · 1 location(s) · Johns Hopkins University · NCT07478887A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Phase 2 · 1 location(s) · Marea Therapeutics · NCT07199309LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05765370Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia
NA · 1 location(s) · Institut Pasteur de Lille · NCT06894251Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability
NA · 1 location(s) · University of Bath · NCT07675603Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a
NA · 1 location(s) · Duke University · NCT06471036A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473Complete Lifestyle Medicine Intervention Program
Phase N/A · 1 location(s) · Northern Ontario School of Medicine · NCT06192251Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
EARLY_Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06615986Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El
NA · 2 location(s) · Sin Gon Kim · NCT07359105A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in P
Phase 3 · 14 location(s) · Aarhus University Hospital · NCT07012629Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target
NA · 1 location(s) · Yonsei University · NCT06231966Causes and Natural History of Dyslipidemias
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00353782Healthy Living Anson Study
NA · 1 location(s) · University of North Carolina, Chapel Hill · NCT07126587
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.